Crescent Biopharma, Inc.
CBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001253689
In the last 90 days, Crescent Biopharma, Inc. insiders filed 1 open-market purchase and 7 sales; 82 institutions reported holding it in 13F filings for Q2 2026, worth $532.6M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Crescent Biopharma, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −6 vs. Q1 2022
- Shares held
- 26.5M
- −857.5K (−3.1%) vs. Q1 2022
- Total value
- $15.8M
- −$15.3M (−49.2%) vs. Q1 2022
- New holders
- 3
- 5 more added
- Sold out
- 9
- 15 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 82 | $532.6M |
| Q1 2026 | 63 | $476.6M |
| Q4 2025 | 58 | $285.9M |
| Q3 2025 | 41 | $134.6M |
| Q2 2025 | 30 | $173.5M |
| Q1 2025 | 35 | $6.46M |
| Q4 2024 | 41 | $7.56M |
| Q3 2024 | 36 | $3.00M |
| Q2 2024 | 35 | $7.20M |
| Q1 2024 | 69 | $110.5M |
| Q4 2023 | 58 | $82.8M |
| Q3 2023 | 49 | $52.1M |
| Q2 2023 | 55 | $61.9M |
| Q1 2023 | 54 | $46.6M |
| Q4 2022 | 48 | $83.3M |
| Q3 2022 | 35 | $14.3M |
| Q2 2022 | 37 | $15.8M |
| Q1 2022 | 44 | $31.2M |
| Q4 2021 | 47 | $42.7M |
| Q3 2021 | 48 | $64.9M |
| Q2 2021 | 58 | $72.5M |
| Q1 2021 | 78 | $110.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Crescent Biopharma, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 9,544,262 | $5.71M | 0.28% | 00.0% | Unchanged |
| NEA Management Company, LLC | 9,089,041 | $5.43M | 0.28% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 1,990,087 | $1.19M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,846,762 | $1.10M | 0.00% | +31,799+1.8% | Added |
| BlackRock Inc. | 768,333 | $459.0K | 0.00% | −99,904−11.5% | Reduced |
| Renaissance Technologies LLC | 566,400 | $339.0K | 0.00% | +95,800+20.4% | Added |
| Millennium Management LLC | 434,655 | $260.0K | 0.00% | +30,466+7.5% | Added |
| Geode Capital Management, LLC | 358,395 | $214.0K | 0.00% | −5,042−1.4% | Reduced |
| Two Sigma Investments, LP | 322,283 | $193.0K | 0.00% | −98,536−23.4% | Reduced |
| Two Sigma Advisers, LP | 317,400 | $190.0K | 0.00% | −71,400−18.4% | Reduced |
| D. E. Shaw & Co., Inc. | 242,023 | $144.0K | 0.00% | −13,661−5.3% | Reduced |
| Bridgeway Capital Management, LLC | 155,400 | $93.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 148,965 | $89.0K | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 119,329 | $71.0K | 0.00% | −41,971−26.0% | Reduced |
| Eversept Partners, LP | 100,579 | $60.1K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 97,797 | $58.0K | 0.00% | 00.0% | Unchanged |
| Intellectus Partners, LLC | 88,000 | $53.0K | 0.02% | −2,500−2.8% | Reduced |
| Charles Schwab Investment Management Inc | 60,353 | $37.0K | 0.00% | +60,353 | New |
| Morgan Stanley | 43,620 | $26.0K | 0.00% | −32−0.1% | Reduced |
| Ieq Capital, LLC | 38,363 | $23.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 26,238 | $16.0K | 0.00% | −61−0.2% | Reduced |
| Susquehanna International Group, LLP | 17,618 | $11.0K | 0.00% | −30,022−63.0% | Reduced |
| Jane Street Group, LLC | 19,154 | $11.0K | 0.00% | +19,154 | New |
| Prentiss Smith & Co Inc | 14,000 | $8.00K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 9,304 | $6.00K | 0.00% | −6,500−41.1% | Reduced |
| Citadel Advisors LLC | 10,796 | $6.00K | 0.00% | −1,723−13.8% | Reduced |
| Tower Research Capital LLC (TRC) | 9,574 | $6.00K | 0.00% | +7,582+380.6% | Added |
| Commonwealth Equity Services, LLC | 10,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 5,063 | $3.00K | 0.00% | −212,053−97.7% | Reduced |
| Hartford Financial Management Inc. | 3,500 | $2.00K | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 2,000 | $1.00K | 0.00% | +2,000 | New |
| BNP Paribas Arbitrage, SA | 481 | $288 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 10 | $0 | 0.00% | −4,109−99.8% | Reduced |
| JPMorgan Chase & Co | 1 | $0 | 0.00% | −1,467−99.9% | Reduced |
| Wells Fargo & Company | 281 | $0 | 0.00% | +26+10.2% | Added |
| Carolinas Wealth Consulting LLC | 395 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 600 | $0 | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −271,129−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −89,926−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −87,678−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −28,004−100.0% | Sold out |
| Sigma Planning Corp | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −10,720−100.0% | Sold out |
| Coastal Bridge Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| FinTrust Capital Advisors, LLC | 0 | $0 | 0.00% | −245−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |